Disparities in Cancer Care | Specialty

The OncLive Disparities in Cancer Care condition center page is a comprehensive resource for clinical news and expert insights on disparities in care with regards to race, gender, demographics, geographics, and socioeconomic status. This page features news articles, interviews in written and video format, and podcasts that focus on studies evaluating these various disparities and how they impact clinical trial enrollment and oncology treatment.

Dr Lathan on Community-based Cancer Evaluation Services in Underserved Patient Groups

April 13th 2023

Christopher Lathan, MD, MS, MPH, discusses socioeconomical and clinical findings from a clinical outreach program incorporating cancer diagnostic services and patient navigation for patients from traditionally underserved populations.

Dr Johnson the Accuracy of Genomic Testing in Black Women With ER+ Breast Cancer

March 30th 2023

Nathalie McDowell Johnson, MD, FACS, discusses the accuracy of genomic testing in Black women with estrogen receptor-positive breast cancer.

Nationwide Initiative Aims to Address Disparities in Early-Phase Cancer Clinical Trials

March 23rd 2023

To expand access to cancer care and research, Stand Up To Cancer® has launched a 4-team initiative across the United States designed to fill in these gaps in care and remove barriers to entry.

Dr Stadler on Enhancing Diversity in Early Phase Clinical Trials For Underserved Communities

March 22nd 2023

Walter M. Stadler, MD, discusses his role within the Stand Up To Cancer® 4-team initiative, where he will aim to enhance diversity in early-phase clinical trials in underserved urban community.

Drs Edelman and Fleisher on Personalizing and Adapting Treatment Approaches in Clinical Trials

March 17th 2023

Martin Edelman, MD, and Linda Fleisher, PhD, MPH, discuss their role within the Stand Up To Cancer® 4-team initiative, focusing on diversity in early-phase clinical trials.

Drs Gerber and Nwachukwu on the Importance of Streamlining Clinical Research in Cancer Care

March 17th 2023

David Gerber, MD, and Chika Nwachukwu, MD, PhD, discuss their role within the Stand Up To Cancer® 4-team initiative, focusing on diversity in early-phase clinical trials.

Drs El-Khoueiry and Hughes-Halbert on the Importance of a Multidisciplinary Approach in Cancer Care

March 17th 2023

Anthony B. El-Khoueiry, MD, and Chanita Hughes-Halbert, PhD, discuss their role within the Stand Up To Cancer® 4-team initiative, focusing on diversity in early-phase clinical trials.

Dr. Johnson on the Importance of Diverse Representation in Breast Cancer Clinical Trials

March 10th 2023

Nathalie McDowell Johnson, MD, FACS, discusses the importance of diverse representation in breast cancer clinical trials.

Dr. Ehrhardt on Factors Associated with Late Mortality in Survivors of Childhood Cancer

February 24th 2023

Matthew J. Ehrhardt, MD, MS, discusses the link between modifiable chronic health conditions and social determinants of health with late mortality for survivors of childhood cancer.

Dr. Kaklamani on Racial Disparities and Clinical Outcomes in the RxPONDER Trial in Breast Cancer

February 22nd 2023

Virginia Kaklamani, MD, discusses how racial disparities may affect patient outcomes and treatment expectations based on data from the RxPONDER trial in breast cancer.

2023 Cancer Trends Highlight Opportunities to Close Gaps in Care in Community Practice

February 14th 2023

A renewed focus on dismantling the barriers and closing gaps in care will aid in the mission to drive down the rate of cancer mortality and incidence across disease states.

NCCN Launches Health Equity Report Card to Address Racial Disparities in Cancer Care

February 10th 2023

The National Comprehensive Cancer Network has partnered with the American Cancer Society Cancer Action Network and the National Minority Quality Forum to launch the new Health Equity Report Card pilot program to address structural and interpersonal bigotry that results in disparities in cancer care and outcomes.

Socioeconomic Factors Are Associated With Disparities in Germline Testing in Pancreatic Cancer

February 5th 2023

Daniel King, MD, PhD, discusses the results of an institutional review evaluating socioeconomic factors associated with disparities for germline genetic testing in patients with pancreatic adenocarcinoma, why germline testing is necessary for thi population, and how he is addressing gaps in germline testing in his own practice.

PhD Candidate Discovers Increasing Risk for Liver Cancer Among US Residents of Mexican Descent

January 26th 2023

The risk for developing hepatocellular carcinoma appears to increase with subsequent generations for Americans of Mexican descent, according to findings from a study of US-born Hispanics/Latinos living in Los Angeles, California.

Older Patients of Color With Cancer Less Likely to Receive Opioids at End of Life

January 12th 2023

Results from a study of 318,549 Medicare beneficiaries with poor-prognosis cancers showed than Black and Hispanic patients were substantially less likely to receive any opioids or long-acting opioids than White patients at the end of life.

Florez Discusses Crucial Aspects of Cancer Care Equity and Survivorship

November 28th 2022

Dr Florez discusses why cancer care equity and survivorship should be a priority for all physicians, the steps the health care system needs to take to address disparities in these areas, and specific ways that Dana-Farber is working to close these gaps.

Stark Differences in Mortality Rates Emphasize Ongoing Racial Disparities in Breast Cancer

October 24th 2022

Bridget A. Oppong, MD, discussed the importance of recognizing and addressing gaps in outcomes between patients with breast cancer in different racial groups. She also addressed the need for better advocacy for Black patients and advocated for improved screening guidelines to close the gap in racial disparities in breast cancer care.

Dr. Chen Discusses Racial Disparities in CTCL

October 21st 2022

Pei-Ling Chen, MD, PhD, discusses epidemiology and racial disparities in CTCL.

Socioeconomic Disparities Associated With Worse OS in Head and Neck Cutaneous Soft Tissue Sarcoma

October 11th 2022

R. Lor Randall, MD, FACS, discusses how disparities may lead to worse outcomes for patients diagnosed with head and neck cutaneous soft tissue sarcomas.

Velcheti Discusses Mobile Telehealth-Based Research to Close Cancer Care Gaps

October 6th 2022

Dr Velcheti discusses planned research into whether mobile technology services can improve patient outcomes for underserved and underrepresented patient populations.